CASI Pharmaceuticals
CASI
#10619
Rank
NZ$7.11 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-88.99%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.62. In 2024 the company made an earnings per share (EPS) of NZ-$4.27 a decrease over its 2023 EPS that were of NZ-$3.37.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.658.83%
2024NZ-$4.2726.73%
2023NZ-$3.37-32.89%
2022NZ-$5.0211.9%
2021NZ-$4.49-38.44%
2020NZ-$7.30-8.96%
2019NZ-$8.0150%
2018NZ-$5.3477.78%
2017NZ-$3.005.88%
2016NZ-$2.84-22.73%
2015NZ-$3.67-76.09%
2014NZ-$15.36318.18%
2013NZ-$3.67-71.79%
2012NZ-$13.0265.96%
2011NZ-$7.85-50%
2010NZ-$15.69-18.97%
2009NZ-$19.37-63.64%
2008NZ-$53.253.57%
2007NZ-$51.42-60.56%
2006NZ-$130.3897.22%
2005NZ-$66.11-2.7%
2004NZ-$67.94-45.59%
2003NZ-$124.87-61.8%
2002NZ-$326.87-25.52%
2001NZ-$438.89-21.38%
2000NZ-$558.2513.86%
1999NZ-$490.30149.53%
1998NZ-$196.4998.15%
1997NZ-$99.1610.2%
1996NZ-$89.98